Is HIAPTEK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HIAPTEK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HIAPTEK (MYR0.34) is trading above our estimate of fair value (MYR0.14)
Significantly Below Fair Value: HIAPTEK is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HIAPTEK?
Key metric: As HIAPTEK is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for HIAPTEK. This is calculated by dividing HIAPTEK's market cap by their current
earnings.
What is HIAPTEK's PE Ratio?
PE Ratio
5.5x
Earnings
RM 106.35m
Market Cap
RM 583.65m
HIAPTEK key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: HIAPTEK is good value based on its Price-To-Earnings Ratio (5.5x) compared to the MY Metals and Mining industry average (12.8x).
Price to Earnings Ratio vs Fair Ratio
What is HIAPTEK's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
HIAPTEK PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
5.5x
Fair PE Ratio
12.3x
Price-To-Earnings vs Fair Ratio: HIAPTEK is good value based on its Price-To-Earnings Ratio (5.5x) compared to the estimated Fair Price-To-Earnings Ratio (12.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.